International Journal of Clinical Research

Objective To explore the clinical characteristics of minocycline in the treatment of dermatological and sexually transmitted diseases. Methods A total of 240 patients with dermatological and sexually transmitted diseases treated in our hospital from June 2024 to June 2025 were selected and grouped based on their conditions. Patients with acne were included in Treatment Group 1, those with skin infections in Treatment Group 2, patients with non-gonococcal urethritis in Treatment Group 3, and those with gonorrhea in Treatment Group 4, with 60 cases in each group. All patients were treated with minocycline, and the clinical efficacy of the drug in dermatological and sexually transmitted disease treatment was analyzed. Results The overall effective rate in Treatment Group 2 was higher at 96.67%, surpassing the clinical treatment outcomes of the other three groups, with a statistically significant difference (P < 0.05). Conclusion The use of minocycline in treating dermatological and sexually transmitted diseases improves efficacy and yields favorable patient outcomes, making it a recommended treatment option.

Minocycline; Dermatological diseases; Treatment efficacy; Non-gonococcal urethritis; Acne